Medtox Scientific — Shareholder Meeting (June 2011)
22 slides from Medtox Scientific's shareholder meeting presentation, Jun 15, 2011
Slide 1: 2011 Annual Stockholders' Meeting
2011 Annual Stockholders’ Meeting June 9, 2011
Slide 2: Financial Performance
Financial Performance Revenue Gross Profit SG8&A % of Sales Operating Income Operating Cash Flow Vv NM ILA Vv
Slide 3: Revenue
Revenue
Slide 4: Revenue
Revenue (in thousands) 2010 2009 Revenues » Annual Growth > Five year CAGR 15.4% 9.0% $97,101 $84,108
Slide 5: Drugs-of-Abuse Testing Services
Drugs-of-Abuse Testing Services ‘Annual Revenue (millions) 40.0 350 300 20.0 15.0 10.0 50 00 > 2010 Revenue Growth 10%
Slide 6: Clinical and Other Lab Services
ical and Other Lab Services ‘Annual Revenue (millions) 2003 2008-2005 «2008 -=«2007-«2008 «2009-2010 > 2010 Revenue Growth 31%
Slide 7: Clinical Trial Services
Clinical Trial Services ‘Annual Revenue (millions) 2003 2008 2005-«=«2006 += 2007~=«2008 «2009-2010 > 2010 Revenue Growth 8%
Slide 8: Product Sales
Product Sales Annual Revenue (millions) 2003 2004 +2005 +2006 «2007 -«2008:~=—«2009-—«2010 > 2010 Revenue Growth 10%
Slide 9: Revenue - Q1
Revenue —- Q1 Mar 31, Mar 31, (in thousands) 2011-QTD __2010- QTD Revenues $25,736 $21,161 > QI Revenue increased 22%
Slide 10: Gross Profit
Gross Profit
Slide 11: Gross Profit
Gross Profit (in thousands) 2010 2009 Gross Profit $39,640 $30,895 Gross Margin 40.8% 36.7% > Gross profit increased 28% to $39.6 million » Gross margin increased 410 basis points to 40.8% of revenue
Slide 12: Gross Profit - Q1
Gross Profit - Q1 Mar 31, Mar 31, (in thousands) 2011 - QTD 2010 - QTD Gross Profit $10,451 $8,100 Gross Margin 40.6% 38.3% > Gross profit increased 29% to $10.4 million > Gross margin increased 230 basis points to 40.6% of revenue
Slide 13: Sales, General & Administrative Expenses
Sales, General & Administrative Expenses
Slide 14: Sales, General & Administrative Expenses
Sales, General & Administrative Expenses % of % of (in thousands) 2010 Sales 2009 Sales SG&A Expense $32,691 33.7% $26,663 31.7%
Slide 15: Sales, General & Administrative Expenses - Q1
Sales, General & Administrative Expenses - Q1 Mar 31, of Mar31, of (in thousands) 2011-QTD sales _2010-QTD Sales SG&A Expense $8,624 33.5% $7,433 35.1%
Slide 16: Operating Income
Operating Income
Slide 17: Operating Income
Operating Income (in thousands) 2010 2009 Operating Income $4,688 $1,968 > Operating income increased 138%
Slide 18: Operating Income - Q1
Operating Income - Q1 Mar 31, Mar 31, (in thousands) 2011 - QTD 2010 - QTD Operating Income $1,233 $118
Slide 19: Operating Cash Flows
Operating Cash Flows
Slide 20: Net Cash Provided by Operating Activities
Net Cash Provided by Operating Activities (in thousands) Dec 31, | Dec 31, 2010 2009 Net cash provided by operating a $10,106 | $6,840
Slide 21: Net Cash Provided by Operating Activities
Net Cash Provided by Operating Activities (in thousands) Mar 31, | Mar 31, 2011 2010 Net cash provided by operating a $1,302 | $921
Slide 22: 2011 Annual Stockholders' Meeting
2011 Annual Stockholders’ Meeting June 9, 2011